Related Experiment Videos
Treatment of acute post-surgical infection of joint arthroplasty
1Department of Infectious Diseases, Hospital Clínic Universitari, IDIBAPS, Barcelona, Spain. asoriano@clinic.ub.es
Abstract:
The best antibiotic regimen for acute prosthetic joint infection, treated without removal of the implant, has not been well-defined. This study describes the use of a protocol based on oral rifampicin combinations to treat 47 cases that were followed prospectively for a 2-year period. The regimen used most commonly was levofloxacin 500 mg/24 h plus rifampicin 600 mg/24 h for a mean duration of 2.7 +/- 1 months. The cure rate was 76.9%, and the only independent risk-factor associated with treatment failure was infection caused by methicillin-resistant Staphylococcus aureus or Enterococcus spp. (OR 17.6, p 0.003). Overall, the results suggested that use of oral antibiotics, including rifampicin, for 2-3 months was a good treatment option.
Insights
Oral antibiotic combinations including rifampicin offer a viable treatment for prosthetic joint infections without implant removal. This approach achieved a 76.9% cure rate in a 2-year study.
Area of Science:
- Infectious Diseases
- Orthopedic Surgery
- Pharmacology
Background:
- The optimal antibiotic treatment for prosthetic joint infections (PJIs) managed non-surgically remains undefined.
- Prosthetic joint infections pose significant challenges in orthopedic surgery.
- Effective non-operative management strategies are crucial for patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of an oral antibiotic regimen, specifically rifampicin combinations, for treating acute prosthetic joint infections without implant removal.
- To determine the cure rate and identify risk factors for treatment failure in this patient cohort.
Main Methods:
- Prospective study of 47 patients with prosthetic joint infections treated with oral antibiotics.
- Commonly used regimen: levofloxacin (500 mg/24 h) plus rifampicin (600 mg/24 h) for a mean duration of 2.7 months.
- Follow-up period of 2 years to assess treatment outcomes.
Main Results:
- A cure rate of 76.9% was achieved with the oral antibiotic protocol.
- Infection by methicillin-resistant Staphylococcus aureus or Enterococcus spp. was the sole independent risk factor for treatment failure (OR 17.6, p=0.003).
- The most frequent regimen involved levofloxacin and rifampicin.
Conclusions:
- Oral antibiotic therapy, particularly rifampicin-based combinations for 2-3 months, represents a favorable treatment option for prosthetic joint infections managed without implant removal.
- This non-operative approach shows promise, though specific resistant pathogens may impact success.
- Further research into optimized oral regimens for PJI is warranted.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis III: Medical Management
Tonsillitis II: Management
Endocarditis IV: Nursing Management
Acute Pyelonephritis I: Introduction
Urinary Tract Calculi VI: Surgical Management